Thomas Soloway
Directeur/Bestuurslid bij THIRD HARMONIC BIO, INC.
Oorsprong van het eerstegraads netwerk van Thomas Soloway
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA.
21
| Extinct | Pharmaceuticals: Major | 21 |
| Public Company | Pharmaceuticals: Major | 20 | |
| Subsidiary | Pharmaceuticals: Major | 13 | |
| Public Company | Pharmaceuticals: Major | 13 | |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.
12
| Extinct | Pharmaceuticals: Major | 12 |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany.
7
| Holding Company | Biotechnology | 7 |
Montreux Equity Partners, Inc.
 Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners, Inc. (Montreux Equity Partners) is a Venture Capital firm founded in 1993 by Dan K. Turner. The firm is headquartered in San Francisco, California.
3
| Private Company | Investment Managers | 3 |
T-Knife Therapeutics, Inc.
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas Soloway via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Public Communications Contact Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin Undergraduate Degree | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Miscellaneous Commercial Services | Chief Executive Officer Sales & Marketing Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Founder | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Operating Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer Chief Executive Officer Director of Finance/CFO | |
| GERON CORPORATION | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Sales & Marketing Chairman General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Private Equity Analyst | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| GLAUKOS CORPORATION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| ASCENDANT RESOURCES INC. | Other Metals/Minerals | Chief Executive Officer Chief Operating Officer | |
| AVROBIO, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Follica, Inc. develops therapies for hair follicle disorders. The firm provides an out-patient therapy coupled with an at-home system for the treatment of androgenetic alopecia (hair loss) and medical device development fields to develop and commercialize its product platform. The company was founded by Rox R. Anderson, George Cotsarelis, Vera Price, Daphne Zohar, David Steinberg, and Bernat Olle in 2006 and is headquartered in Boston, MA. | Other Consumer Services | Director/Board Member Chairman | |
| Pepperdine University | College/University | Masters Business Admin Masters Business Admin | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Compliance Officer Director/Board Member | |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| Kellogg School of Management | College/University | Masters Business Admin Graduate Degree | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Public Communications Contact Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Denemarken | 3 |
| Japan | 2 |
| Canada | 2 |
| Ierland | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 10 |
| Finance | 6 |
| Commercial Services | 5 |
| Non-Energy Minerals | 2 |
Operationeel
| Director/Board Member | 630 |
| Corporate Officer/Principal | 249 |
| Independent Dir/Board Member | 180 |
| Chairman | 142 |
| Chief Executive Officer | 77 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Daniel Bradbury | 45 |
| Heath Lukatch | 43 |
| Jonathan Silverstein | 42 |
| John P. Walker | 39 |
| Kathy LaPorte | 34 |
| Howard D. Palefsky | 31 |
| Robert Perez | 31 |
| Albert Cha | 30 |
| Camille Samuels | 30 |
| Dan Turner | 29 |
| Laura Brege | 27 |
| David Bonita | 27 |
| Mark Iwicki | 26 |
| Lars Holtug | 26 |
- Beurs
- Insiders
- Thomas Soloway
- Bedrijfsconnecties
